Q3 2024
|
37 |
2,013,442 |
VTI, TEM, BN.TO, EWTX
|
13F-HR
|
10/24/2024 |
000095012324009887 |
Q2 2024
|
38 |
1,854,897 |
VTI, BN.TO, TEM, ASML
|
RESTATEMENT
|
8/20/2024 |
000095012324008900 |
Q1 2024
|
35 |
1,449,667 |
ASML, BN.TO, CRM, EPC
|
13F-HR
|
5/15/2024 |
000095012324005208 |
Q4 2023
|
36 |
1,619,344 |
BN.TO, ASML, CRM, SPRO
|
13F-HR
|
2/14/2024 |
000095012324002161 |
Q3 2023
|
40 |
1,353,229 |
BN.TO, ASML, CRM, CORT
|
13F-HR
|
11/14/2023 |
000095012323010600 |
Q2 2023
|
41 |
1,294,170 |
ASML, CRM, LNZA, CORT
|
13F-HR
|
8/14/2023 |
000095012323007714 |
Q1 2023
|
47 |
1,515,634 |
ASML, CRM, CYT, BKAA.SG
|
13F-HR
|
5/15/2023 |
000095012323005002 |
Q4 2022
|
48 |
1,601,649 |
SYK, ASML, STE, CRM
|
13F-HR
|
2/14/2023 |
000095012323002359 |
Q3 2022
|
52 |
2,097,264 |
VTI, SYK, CTLT, BKAA.SG
|
13F-HR
|
11/14/2022 |
000095012322011721 |
Q2 2022
|
54 |
2,030,708 |
VTI, CTLT, SYK, BSX
|
13F-HR
|
8/15/2022 |
000095012322009223 |
Q1 2022
|
51 |
1,895,744 |
VTI, BKAA.SG, BSX, ASML
|
RESTATEMENT
|
5/27/2022 |
000095012322006736 |
Q4 2021
|
48 |
2,111,971 |
VTI, EXAI, BKAA.SG, AAPL
|
13F-HR
|
2/14/2022 |
000095012322002394 |
Q3 2021
|
49 |
1,933,270 |
VTI, BKAA.SG, BSX, AAPL
|
13F-HR
|
11/15/2021 |
000095012321015112 |
Q2 2021
|
54 |
2,254,350 |
VTI, BKAA.SG, MORF, AAPL
|
13F-HR
|
8/16/2021 |
000095012321011090 |
Q1 2021
|
51 |
2,421,558 |
VTI, EWTX, MORF, BOLT
|
13F-HR
|
5/17/2021 |
000095012321006729 |
Q4 2020
|
45 |
2,332,562 |
VTI, NKTX, INGN, AAPL
|
13F-HR
|
2/16/2021 |
000095012321002364 |
Q3 2020
|
42 |
2,014,483 |
VTI, AAPL, CTLT, HRMY
|
13F-HR
|
11/16/2020 |
000095012320011935 |
Q2 2020
|
35 |
1,549,081 |
VTI, AAPL, INGN, CABO
|
13F-HR
|
8/14/2020 |
000095012320008748 |
Q1 2020
|
30 |
1,498,340 |
VTI, INGN, CABO, AAPL
|
13F-HR
|
5/15/2020 |
000095012320005049 |
Q4 2019
|
29 |
1,552,731 |
VTI, INGN, CABO, AAPL
|
13F-HR
|
2/14/2020 |
000095012320002402 |
Q3 2019
|
29 |
583,699 |
INGN, AAPL, CABO, MIST
|
13F-HR
|
11/14/2019 |
000095012319011293 |
Q2 2019
|
29 |
713,755 |
INGN, MIST, AAPL, CABO
|
13F-HR
|
8/14/2019 |
000095012319008284 |
Q1 2019
|
22 |
675,969 |
INGN, GKOS, CABO, KIDS
|
13F-HR
|
5/15/2019 |
000095012319005344 |
Q4 2018
|
23 |
710,313 |
INGN, GKOS, SEASPINE HLDGS CORP, KIDS
|
13F-HR
|
2/14/2019 |
000095012319002137 |
Q3 2018
|
1 |
3,766 |
C
|
NEW HOLDINGS
|
2/6/2019 |
000095012319000714 |
Q3 2018
|
22 |
1,255,861 |
INGN, GKOS, CRVS, XLRN
|
13F-HR
|
11/14/2018 |
000095012318011813 |
Q2 2018
|
1 |
3,513 |
C
|
NEW HOLDINGS
|
2/6/2019 |
000095012319000712 |
Q2 2018
|
18 |
991,060 |
INGN, XLRN, CRVS, MRUS
|
13F-HR
|
8/14/2018 |
000095012318008820 |
Q1 2018
|
17 |
797,426 |
INGN, XLRN, VYNE, CRVS
|
13F-HR
|
5/15/2018 |
000095012318005553 |
Q4 2017
|
14 |
713,357 |
INGN, XLRN, DERM, CRVS
|
13F-HR
|
2/14/2018 |
000095012318002147 |
Q3 2017
|
17 |
768,329 |
INGN, XLRN, DERM, CRVS
|
13F-HR
|
11/14/2017 |
000095012317010699 |
Q2 2017
|
21 |
835,774 |
INGN, ANAB, XLRN, SPNC
|
13F-HR
|
8/14/2017 |
000095012317007698 |
Q1 2017
|
22 |
939,094 |
INGN, ANAB, RETA, IRTC
|
13F-HR
|
5/15/2017 |
000095012317005095 |
Q4 2016
|
22 |
1,050,041 |
INGN, VTI, CLCD, VGK
|
13F-HR
|
2/14/2017 |
000095012317002225 |
Q3 2016
|
17 |
1,125,983 |
VTI, INGN, ISEE, CLCD
|
13F-HR
|
11/14/2016 |
000095012316022226 |
Q2 2016
|
18 |
952,621 |
VTI, ISEE, INGN, VGK
|
13F-HR
|
8/15/2016 |
000095012316019962 |
Q1 2016
|
17 |
912,485 |
VTI, ISEE, INGN, VGK
|
13F-HR
|
5/16/2016 |
000095012316017459 |
Q4 2015
|
14 |
1,040,415 |
ISEE, VTI, INGN, VGK
|
13F-HR
|
2/16/2016 |
000095012316014860 |
Q3 2015
|
19 |
967,913 |
VTI, ISEE, INGN, VGK
|
13F-HR
|
11/16/2015 |
000095012315012026 |
Q2 2015
|
19 |
1,390,516 |
VTI, ISEE, INGN, WRIGHT MEDICAL GROUP
|
13F-HR
|
8/14/2015 |
000095012315009039 |
Q1 2015
|
15 |
1,175,668 |
VTI, ISEE, VGK, INGN
|
13F-HR
|
5/15/2015 |
000095012315006094 |
Q4 2014
|
15 |
1,236,066 |
VTI, ISEE, INGN, VGK
|
13F-HR
|
2/17/2015 |
000095012315002217 |
Q3 2014
|
13 |
1,025,645 |
VTI, ISEE, VGK, INGN
|
13F-HR
|
11/14/2014 |
000095012314011904 |
Q2 2014
|
10 |
1,011,197 |
VTI, ISEE, VGK, INGN
|
NEW HOLDINGS
|
11/14/2014 |
000095012314011903 |
Q2 2014
|
8 |
986,350 |
VTI, ISEE, VGK, INGN
|
13F-HR
|
8/14/2014 |
000110465914060605 |
Q1 2014
|
8 |
810,998 |
VTI, ISEE, VGK, INGN
|
NEW HOLDINGS
|
11/14/2014 |
000095012314011901 |
Q1 2014
|
6 |
791,333 |
VTI, ISEE, VGK, INGN
|
13F-HR
|
8/14/2014 |
000110465914060604 |
Q4 2013
|
7 |
680,963 |
VTI, ISEE, VGK, WMGI
|
NEW HOLDINGS
|
11/14/2014 |
000095012314011899 |
Q4 2013
|
5 |
659,209 |
VTI, ISEE, VGK, TETRAPHASE PHARMACEUTICALS INC
|
13F-HR
|
8/14/2014 |
000110465914060602 |
Q3 2013
|
5 |
403,786 |
VTI, VGK, WMGI, PTCT
|
13F-HR
|
11/14/2014 |
000095012314011896 |
Q2 2013
|
4 |
597,040 |
VTI, VGK, WMGI, WRIGHT MED GROUP INC
|
13F-HR
|
11/14/2014 |
000095012314011895 |
Q1 2013
|
4 |
589,855 |
VTI, VGK, WMGI, WRIGHT MED GROUP INC
|
13F-HR
|
11/14/2014 |
000095012314011894 |
Q4 2012
|
3 |
549,815 |
VTI, VGK, BIOMIMETIC THERAPEUTICS INC
|
13F-HR
|
11/14/2014 |
000095012314011892 |
Q3 2012
|
3 |
522,173 |
VTI, VGK, BIOMIMETIC THERAPEUTICS INC
|
13F-HR
|
11/14/2014 |
000095012314011891 |
Q2 2012
|
3 |
488,213 |
VTI, VGK, BIOMIMETIC THERAPEUTICS INC
|
13F-HR
|
11/14/2014 |
000095012314011890 |
Q1 2012
|
3 |
511,754 |
VTI, VGK, BIOMIMETIC THERAPEUTICS INC
|
13F-HR
|
11/14/2014 |
000095012314011888 |
Q4 2011
|
3 |
460,144 |
VTI, VGK, BIOMIMETIC THERAPEUTICS INC
|
13F-HR
|
11/14/2014 |
000095012314011885 |
Q3 2011
|
4 |
437,206 |
VTI, VGK, BIOMIMETIC THERAPEUTICS INC, EWJ
|
13F-HR
|
11/14/2014 |
000095012314011884 |
Q2 2011
|
4 |
403,094 |
VTI, VGK, BIOMIMETIC THERAPEUTICS INC, EWJ
|
13F-HR
|
11/14/2014 |
000095012314011881 |
Q1 2011
|
4 |
438,337 |
VTI, VGK, BIOMIMETIC THERAPEUTICS INC, EWJ
|
13F-HR
|
11/14/2014 |
000095012314011880 |
Q4 2010
|
4 |
416,500 |
VTI, VGK, BIOMIMETIC THERAPEUTICS INC, EWJ
|
13F-HR
|
11/14/2014 |
000095012314011879 |
Q3 2010
|
4 |
344,712 |
VTI, VGK, BIOMIMETIC THERAPEUTICS INC, EWJ
|
13F-HR
|
11/14/2014 |
000095012314011876 |
Q2 2010
|
4 |
272,784 |
VTI, VGK, BIOMIMETIC THERAPEUTICS INC, EWJ
|
13F-HR
|
11/14/2014 |
000095012314011875 |
Q1 2010
|
4 |
315,867 |
VTI, VGK, BIOMIMETIC THERAPEUTICS INC, EWJ
|
13F-HR
|
11/14/2014 |
000095012314011872 |
Q4 2009
|
4 |
281,465 |
VTI, VGK, BIOMIMETIC THERAPEUTICS INC, EWJ
|
13F-HR
|
11/14/2014 |
000095012314011863 |